The Pasteur company said it was ready to “test and vaccinate”, at the request of the authorities

by time news

2024-08-19 15:36:40

A caregiver at an mpox treatment center in Nyiragongo, Democratic Republic of Congo, August 17, 2024.

Two years after treating patients with mpox during the previous monkeypox epidemic, the Pasteur Institute said it was ready to “test and vaccine” new Inside we click Release remembering the recent situation of the renewal of the viral disease, the organization confirmed Monday August 19 that it “Emergency intervention cell” now analyze, “at the request of health authorities, suspicious samples” Made in Parisian hospitals or within your medical center.

Read also This article is reserved for our subscribers Mpox virus: are we at risk of global spread of a new variant?

The latter, specializing in travel medicine, “Take your internal procedure and test patients who show symptoms that are suggestive of mpox (…) in the best security conditions ». He also said that he was holding “in the hands of the health authorities to vaccinate within its walls everyone from the population targeted by the health recommendations currently being reviewed”.

The day after the recording in Sweden of the first case of infection with the mpox variant, corresponding to the type 1b clade, the first outside of Africa, the French Prime Minister, Gabriel Attal, announced on Friday the state of the French health system in “high alert status”after a first point with the minister responsible for the topic.

After a government meeting on Monday on this topic, the government confirmed that“Until today, No damage by clade 1 has yet been recorded in France”, in a “sanitary point” published Monday evening. But the Pasteur Institute is preparing for this event: ” In the event of a positive test, patient care will be provided in conjunction with the reference health establishments, with which the Institut Pasteur maintains close collaboration. »

“Serious medical condition”

Ask Saturday about France Inter on the subject of vaccination, Karine Lacombe, infectious disease specialist and head of the infectious disease center at the Saint-Antoine hospital, thinks that“you have to have hope”. “Vaccines are available for different populations, and manufacturers are on deck to increase productionhe assured. (…) There is no concern about access to vaccines. »

Even so, for Yasmine Belkaid, director general of the Institut Pasteur, “This is a serious health condition, which is needed by all [leur] caution ». Wednesday August 14, faced with the renewal of cases of mpox in Africa, especially those corresponding to clade 1b, which is more lethal than other variants, the World Health Organization has drawn the highest level of healthy alertness.

He also recommended on Monday that the countries affected by the mpox vaccine launch programs in areas where cases have appeared. The World Health Organization also calls on the countries involved to establish or strengthen emergency response coordination mechanisms at national and regional levels, to strengthen disease surveillance and monitoring, by differentiating between clades, and to report cases to him. “On a timely basis and on a weekly basis”.

Read also This article is reserved for our subscribers Why has the WHO classified the mpox epidemic in Africa as a “public health emergency of international concern”

World with AFP

Reuse this content

#Pasteur #company #ready #test #vaccinate #request #authorities

You may also like

Leave a Comment